Contributed by Dr. Ashok Tamhankar and Dr. Nishtha Khatri
Nitric Oxide Nasal Spray (NONS) has been previously tested for effectiveness in various viral infections such as influenza and H1N1. Currently, several clinical trials with NORS have been conducted to determine its safety and efficacy in COVID-19 treatment as well as prevention. As per results obtained from a randomised double-blind, placebo controlled phase II trial, the NONS nasal spray significantly reduced the viral load of SARS-CoV-2 (99 % in 72 hours). Moreover, no major adverse events were reported. NONS could seem as a ray of hope in our fight against COVID-19.
